|
|
|
Insider
Information: |
Hyde Joseph R III |
Relationship: |
Director |
City: |
Memphis |
State: |
TN |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
4,411,298 |
|
Indirect Shares
|
2,672,247 |
|
|
Direct
Value |
$245,254,219 |
|
|
Indirect Value
|
$6,749,827 |
|
|
Total
Shares |
7,083,545 |
|
|
Total
Value |
$252,004,046 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Fedex Corp |
FDX |
Director |
2009-04-29 |
132,000 |
2008-11-03 |
0 |
Premium* |
|
Oncternal Therapeutics Inc |
ONCT |
Director, 10% Owner |
2019-01-02 |
4,207,368 |
2019-01-02 |
2,670,247 |
Premium* |
|
Autozone Inc |
AZO |
Director |
2018-01-01 |
71,930 |
2018-01-01 |
2,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
178 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 8
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ONCT |
Oncternal Therapeutics In... |
Director |
|
2008-03-11 |
4 |
A |
$13.27 |
$517,335 |
I/I |
38,716 |
715,716 |
0 |
- |
|
ONCT |
Oncternal Therapeutics In... |
Director |
|
2010-05-05 |
4 |
B |
$3.47 |
$69,400 |
I/I |
20,000 |
735,716 |
2.25 |
- |
|
ONCT |
Oncternal Therapeutics In... |
Director |
|
2004-02-02 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
754,800 |
|
- |
|
ONCT |
Oncternal Therapeutics In... |
Director |
|
2010-05-06 |
4 |
B |
$3.36 |
$67,200 |
I/I |
20,000 |
755,716 |
2.25 |
- |
|
ONCT |
Oncternal Therapeutics In... |
Director |
|
2010-05-07 |
4 |
B |
$3.25 |
$62,355 |
I/I |
19,198 |
774,914 |
2.25 |
- |
|
ONCT |
Oncternal Therapeutics In... |
Director |
|
2010-05-10 |
4 |
B |
$3.32 |
$66,440 |
I/I |
20,000 |
794,914 |
2.25 |
- |
|
ONCT |
Oncternal Therapeutics In... |
Director |
|
2010-05-11 |
4 |
B |
$3.59 |
$71,820 |
I/I |
20,000 |
814,914 |
2.25 |
- |
|
ONCT |
Oncternal Therapeutics In... |
Director |
|
2010-05-12 |
4 |
B |
$3.70 |
$92,525 |
I/I |
25,000 |
839,914 |
2.25 |
- |
|
ONCT |
Oncternal Therapeutics In... |
Director |
|
2010-05-17 |
4 |
B |
$3.74 |
$10,452 |
I/I |
2,794 |
845,109 |
2.17 |
- |
|
ONCT |
Oncternal Therapeutics In... |
Director |
|
2010-05-27 |
4 |
B |
$2.04 |
$408,000 |
I/I |
200,000 |
1,045,109 |
2.25 |
- |
|
ONCT |
Oncternal Therapeutics In... |
Director |
|
2010-05-28 |
4 |
B |
$2.01 |
$301,500 |
I/I |
150,000 |
1,195,109 |
2.25 |
- |
|
ONCT |
Oncternal Therapeutics In... |
Director |
|
2010-06-01 |
4 |
B |
$2.07 |
$186,300 |
I/I |
90,000 |
1,285,109 |
2.25 |
- |
|
ONCT |
Oncternal Therapeutics In... |
Director |
|
2010-06-02 |
4 |
B |
$2.16 |
$208,991 |
I/I |
96,755 |
1,381,864 |
2.25 |
- |
|
ONCT |
Oncternal Therapeutics In... |
Director |
|
2010-06-03 |
4 |
B |
$2.41 |
$117,078 |
I/I |
48,580 |
1,430,444 |
2.25 |
- |
|
ONCT |
Oncternal Therapeutics In... |
Director |
|
2010-06-04 |
4 |
B |
$2.69 |
$201,750 |
I/I |
75,000 |
1,505,444 |
2.25 |
- |
|
ONCT |
Oncternal Therapeutics In... |
Director |
|
2010-06-07 |
4 |
B |
$2.60 |
$431,961 |
I/I |
166,139 |
1,671,583 |
2.25 |
- |
|
ONCT |
Oncternal Therapeutics In... |
Director |
|
2010-06-08 |
4 |
B |
$2.60 |
$114,746 |
I/I |
44,133 |
1,715,716 |
2.25 |
- |
|
ONCT |
Oncternal Therapeutics In... |
Director |
|
2018-01-02 |
4 |
A |
$11.46 |
$15,625 |
D/D |
1,363 |
1,734,893 |
0 |
- |
|
ONCT |
Oncternal Therapeutics In... |
Director |
|
2018-04-02 |
4 |
A |
$17.47 |
$15,625 |
D/D |
894 |
1,927,773 |
0 |
- |
|
ONCT |
Oncternal Therapeutics In... |
Director |
|
2018-07-02 |
4 |
A |
$15.47 |
$15,625 |
D/D |
1,010 |
1,928,783 |
0 |
- |
|
ONCT |
Oncternal Therapeutics In... |
Director |
|
2018-10-01 |
4 |
A |
$1.50 |
$15,625 |
D/D |
10,417 |
1,939,199 |
0 |
- |
|
ONCT |
Oncternal Therapeutics In... |
Director |
|
2017-04-03 |
4 |
A |
$4.90 |
$15,625 |
D/D |
3,189 |
2,075,287 |
0 |
- |
|
ONCT |
Oncternal Therapeutics In... |
Director |
|
2010-11-01 |
4 |
B |
$2.80 |
$6,160,000 |
I/I |
2,200,000 |
3,915,716 |
2.25 |
- |
|
ONCT |
Oncternal Therapeutics In... |
Director |
|
2017-09-29 |
4 |
A |
$0.00 |
$0 |
D/D |
1,130,582 |
3,981,562 |
0 |
- |
|
ONCT |
Oncternal Therapeutics In... |
Director |
|
2017-10-02 |
4 |
A |
$7.94 |
$15,625 |
D/D |
1,968 |
3,983,530 |
0 |
- |
|
178 Records found
|
|
Page 4 of 8 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|